<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR868.html">Part 868
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 868.1120  Indwelling blood oxyhemoglobin concentration analyzer.
                            </h3>
                            <p class="depth1"><em>(a)</em> Identification. An indwelling blood oxyhemoglobin concentration  analyzer   is a photoelectric device used to measure, in vivo, the oxygen-carrying  capacity of hemoglobin in blood to aid in determining the patient's  physiological status.</p><p class="depth1"><em>(b)</em> Classification. Class III (premarket approval).</p><p class="depth1"><em>(c)</em> Date PMA or notice of completion of PDP is required. A PMA or  notice of completion of a PDP is required to be filed with the Food and  Drug Administration on or before September 21, 2004, for any indwelling  blood oxyhemoglobin concentration analyzer that was in commercial  distribution before May 28, 1976, or that has, on or before September  21, 2004, been found to be substantially equivalent to an indwelling  blood oxyhemoglobin concentration analyzer that was in commercial  distribution before May 28, 1976. Any other indwelling blood  oxyhemoglobin concentration analyzer shall have an approved PMA or  declared completed PDP in effect before being placed in commercial  distribution.  [47 FR 31142, July 16, 1982, as amended at 52 FR 17735, May 11, 1987; 52  FR 22577, June 12, 1987; 69 FR 34920, June 23, 2004]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
